TAPI develops and manufactures active pharmaceutical ingredients (APIs) for the global pharmaceutical industry. With over 85 years of expertise in this specialisation, the company operates 13 sites spanning from Israel to India and employs more than 4,100 professionals. It serves as a trusted partner for 80% of the world's top 50 pharmaceutical companies, providing critical inputs for drug development and production.
The company's operations span the full spectrum of API work: research and development, chemical and biopharmaceutical engineering, manufacturing, and quality assurance. Its technical capabilities rest on deep expertise in pharmaceutical science and cutting-edge manufacturing technology, supported by a workforce of scientists, engineers and manufacturing specialists.
TAPI describes itself as a community rather than a conventional company, emphasising collaboration across its global sites and functions. The organisation places weight on scientific curiosity combined with practical problem-solving, alongside an stated commitment to quality and an approach it frames as "beyond is where we begin." The company actively encourages ownership and cross-cultural engagement among its employees.
